Essex Bio-Technology (HKSE:01061) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01061 Essex Bio-Technology Ltd HKSE:01061
86 GF Score
Price HK$2.29
GF Value HK$3.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Essex Bio-Technology Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:01061 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Essex Bio-Technology Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's Short Interest distribution charts can be found below:

* The bar in red indicates where Essex Bio-Technology's Short Interest falls into.


HKSE:01061
86GF Score
Essex Bio-Technology Ltd HKSE:01061
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Essex Bio-Technology (HKSE:01061) Overvalued in 2026?

Based on GuruFocus' analysis, Essex Bio-Technology stock appears to be undervalued. The current stock price of HK$2.29 is trading 26.8% below its estimated GF Value™ of HK$3.13. GuruFocus considers Essex Bio-Technology to be Modestly Undervalued.

Key valuation signals for HKSE:01061:

  • Short Interest:
  • GF Value™: HK$3.13 vs. price of HK$2.29 (26.8% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the HKSE:01061 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Essex Bio-Technology Business Description

Address No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture, and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, and Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel, and mouthwash. The majority of the group's revenue comes from the PRC, also operates in Hong Kong and other countries.
86GF Score

Get the complete analysis for HKSE:01061

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.29
Price
HK$3.13
GF Value